Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: testify (1), bear witness (18)

Papers Sept 2020 held in closed session due to Covid-19

Description: Date Time Location Chair Agenda - Trust Board Meeting 29/09/2020 9:00 - 16:00 Microsoft Teams Peter Hollins 1 Chair’s Welcome, Apologi
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2020/papers-sept-2020-held-in-closed-session-due-to-covid-19.pdf

Papers Trust Board - 11 March 2025

Description: Date Time Location Chair Agenda Trust Board – Open Session 11/03/2025 9:00 - 13:00 Conference Room, Heartbeat Education Centre
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-11-March-2025.pdf

Epi for Clinicians 2023 Advert

Description: EPIDEMIOLOGY FOR CLINICIANS A practical introduction to epidemiological research An introduction to epidemiology for those
Url: /Media/Southampton-Clinical-Research/Downloads/Epi-for-Clinicians-2023-Advert.pdf

Ipilimumab-Nivolumab Ver1

Description: Chemotherapy Protocol MESOTHELIOMA IPILIMUMAB-NIVOLUMAB Regimen • Mesothelioma – Ipilimumab-Nivolumab Indication • Nivolumab in combination with
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Mesothelioma/Ipilimumab-Nivolumab-Ver1.pdf

Communicating risk: words or numbers?

Description: Is it better to communicate risks to patients with words or statistics?
Url: /HealthProfessionals/Clinical-law-updates/Communicating-risk-words-or-numbers.aspx

Nasogastric tubes: a narrow dispute

Description: Mr W, a 77 year old man with end stage dementia, lacked capacity to make decisions about his treatment.
Url: /HealthProfessionals/Clinical-law-updates/Nasogastric-tubes-a-narrow-dispute.aspx

Handling concerns and complaints policy

Description: Handling Complaints Policy, Version 13.0 Trust reference PET003 Version number 13.0 Description Policy to explain how Unive
Url: /Media/UHS-website-2019/Docs/Policies/Handling-concerns-and-complaints-policy.pdf

Trastuzumab (21 day-Maintenance)

Description: Chemotherapy Protocol BREAST CANCER TRASTUZUMAB (21 day- Maintenance) Regimen • Breast Cancer – Trastuzumab (21 day-Maintenance) Indi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Trastuzumab-21-day-Maintenance.pdf

Trastuzumab (21 day-Load)

Description: Chemotherapy Protocol BREAST CANCER TRASTUZUMAB (21 day-Load) Regimen • Breast Cancer – Trastuzumab (21 day-Load) Indication • Adjuva
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Trastuzumab-21-day-Load.pdf

Trastuzumab Main

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER TRASTUZUMAB (21 day-Maintenance) Regimen • GI (upper) – Trastuzumab (21 day-Mai
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/TrastuzumabMainVer1.2.pdf

31 to 40 of 354

Previous … 2 3 4 5 6 … Next